Breast Imaging Technologies Market to expand at a healthy 8.7% CAGR from 2020 to 2030


The Global Breast Imaging Technologies Market held USD 3,412.47 million in 2019 and is predicted to reach USD 9,285.89 million by 2030 with a CAGR of 8.7% from 2020-2030     

Read Report Overview @

Breast imaging technologies are used to provide high-resolution images of breast tissues. These imaging are based on ionizing and non-ionizing imaging technologies that help in early detection and diagnosis of breast diseases, especially breast cancer in women.

Spreading awareness about breast cancer is an effort to raise awareness and reduce the stigma of breast cancer through education on symptoms and treatment. According to a survey conducted by GLOBOCAN stated that in year 2015 around 1.8 million new breast cancer cases were estimated and it is estimated that this number will further projected to reach around 2.4 million by 2030. Hence, the demand of breast imaging technologies is anticipated to rise during the forecast period.

The breast imaging technologies market size is projected to increase at a notable rate during the forecasted period owing to rising occurrences of breast cancer. Also, increasing investments in R&D of breast cancer diagnostics, and government’s efforts to increase awareness has majorly driven the breast imaging technologies market. The increasing geriatric population has further supplemented the market growth. However, high cost of imaging systems, errors and side effects associated with breast screening, and stringent regulations is hampering the growth of the breast imaging technologies market. The economic and infrastructural development in emerging countries will create new opportunities for the breast imaging technologies market share in future.

The breast imaging technologies market is segmented on the basis of technology and geography. On the basis of technology, the breast imaging technologies market is segmented into ionizing and non-ionizing. The ionizing segment is further divided into full-field digital mammography, cone-beam computed tomography, analog mammography, positron emission tomography & computed tomography, positron emission mammography, electric impedance tomography, 3D breast tomosynthesis, and MBI/BSGI. The non-ionizing segment is further sub segmented into MRI, optical imaging, automated whole-breast ultrasound, thermography, and ultrasound. Geographic breakdown and analysis of each of the aforesaid segments includes regions comprising North America, Europe, Asia-Pacific, and LAMEA.

North America denotes a higher adoption of the breast imaging technologies due to developments in healthcare and related infrastructure, high R&D investments, better reimbursement facility, high consumer awareness, and technological advancements.

It is expected that the emerging economies, specifically in the Asia-Pacific region would witness increasing market size owing to supportive government policies, increasing incidence of breast cancer, and healthcare expenditure.

Request to view Sample Report:

Comprehensive competitive analysis and profiles of the major market players such as GE Healthcare, Hologic, Inc., Fujifilms Holdings Corp., SonoCine, Inc., Philips Healthcare, Gamma Medica, Inc., Siemens Healthcare, Toshiba Corporation, Dilon Technologies, Inc., Aurora Imaging Technology, Inc., and others are provided in the breast imaging technologies market report.

Comments

Popular posts from this blog

Orthobiologics Market to rise to USD 5.31 billion by the end of 2030

Chemical Tanker Shipping Market is predicted to reach USD 44.48 billion by 2030

Narcolepsy Drug Market is expected to demonstrate a CAGR of 7.9% by 2030